Page 2 - Eye Associates News Today

Completed enrollment in Phase 2b RELIEF trial of Licaminlimab , anti-TNF alpha eye drops in Dry Eye Disease ; topline results expected in Q2 2024Second Phase 3 trial of OCS-01 eye drops in Diabetic...

Harvard Eye Associates Now Offering iDose(R) TR as a New Treatment ...

Looking for healthcare providers in Dayton? Our Dayton Health Directory provides links to local health care services and professionals, as well as businesses supporting healthy lifestyles and fitness related services located in Dayton and the surrounding area.

The City of Charlestown will host its annual Health and Wellness Fair on Tuesday, Feb. 13 at the Arts & Enrichment Center, 999 Water St., Charlestown. The fair takes place

51 wet AMD patients with severe disease activity and high treatment burden were randomized to high or low dose 4D-150 or aflibercept control regimen4D-150 was well tolerated with a favorable...

- Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47th Annual Meeting of the Macula Society, with...

A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health...

Several nonprofit organizations and businesses across East Texas will be closed for Monday, Jan.15 and Tuesday, Jan. 16, due to the wintry weather.

ROCKVILLE, Md., Jan. 10, 2024 /PRNewswire/ -- REGENXBIO Inc. today announced that it will present data from the Phase II AAVIATE® trial of suprachoroidal ABBV-RGX-314 for the treatment of wet...

/PRNewswire/ -- Florida Eye Specialists, the largest eye practice in North Florida, and International Eye Associates, a trusted Ormond Beach practice of over...